+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anemia and leukopenia following intravenous colloidal silver infusions—Clinical and hematological features, unique peripheral blood film appearance and effective therapy with supplemental oral copper and apheresis

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Alternative medical therapy with multiple intravenous colloidal silver infusions may cause severe illness, including profound copper deficiency‐induced anemia and hepatic toxicity. No chelating agent for silver poisoning exists and effective therapy requires apheresis in combination with continuous administration of oral copper.

          Related collections

          Most cited references 16

          • Record: found
          • Abstract: found
          • Article: not found

          A Pharmacological and Toxicological Profile of Silver as an Antimicrobial Agent in Medical Devices

          Silver is used widely in wound dressings and medical devices as a broad-spectrum antibiotic. Metallic silver and most inorganic silver compounds ionise in moisture, body fluids, and secretions to release biologically active Ag+. The ion is absorbed into the systemic circulation from the diet and drinking water, by inhalation and through intraparenteral administration. Percutaneous absorption of Ag+ through intact or damaged skin is low. Ag+ binds strongly to metallothionein, albumins, and macroglobulins and is metabolised to all tissues other than the brain and the central nervous system. Silver sulphide or silver selenide precipitates, bound lysosomally in soft tissues, are inert and not associated with an irreversible toxic change. Argyria and argyrosis are the principle effects associated with heavy deposition of insoluble silver precipitates in the dermis and cornea/conjunctiva. Whilst these changes may be profoundly disfiguring and persistent, they are not associated with pathological damage in any tissue. The present paper discusses the mechanisms of absorption and metabolism of silver in the human body, presumed mechanisms of argyria and argyrosis, and the elimination of silver-protein complexes in the bile and urine. Minimum blood silver levels consistent with early signs of argyria or argyrosis are not known. Silver allergy does occur but the extent of the problem is not known. Reference values for silver exposure are discussed.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review

            Toxic metals such as arsenic, cadmium, lead, and mercury are ubiquitous, have no beneficial role in human homeostasis, and contribute to noncommunicable chronic diseases. While novel drug targets for chronic disease are eagerly sought, potentially helpful agents that aid in detoxification of toxic elements, chelators, have largely been restricted to overt acute poisoning. Chelation, that is multiple coordination bonds between organic molecules and metals, is very common in the body and at the heart of enzymes with a metal cofactor such as copper or zinc. Peptides glutathione and metallothionein chelate both essential and toxic elements as they are sequestered, transported, and excreted. Enhancing natural chelation detoxification pathways, as well as use of pharmaceutical chelators against heavy metals are reviewed. Historical adverse outcomes with chelators, lessons learned in the art of using them, and successes using chelation to ameliorate renal, cardiovascular, and neurological conditions highlight the need for renewed attention to simple, safe, inexpensive interventions that offer potential to stem the tide of debilitating, expensive chronic disease.
              • Record: found
              • Abstract: not found
              • Article: not found

              Copper deficiency anemia: review article


                Author and article information

                Clin Case Rep
                Clin Case Rep
                Clinical Case Reports
                John Wiley and Sons Inc. (Hoboken )
                09 August 2019
                September 2019
                : 7
                : 9 ( doiID: 10.1002/ccr3.v7.9 )
                : 1757-1762
                [ 1 ] Department of Clinical Medicine Weill Cornell Medical College New York NY USA
                [ 2 ] Department of Academic Medicine Houston Methodist Hospital, Methodist Hospital Research Institute Houston TX USA
                [ 3 ] Houston Methodist Hospital Houston TX USA
                [ 4 ] School of Public Health University of Colorado Boulder CO USA
                [ 5 ] School of Pharmacy University of Colorado Boulder CO USA
                [ 6 ] Summit Technology, LLP West Hartford CT USA
                Author notes
                [* ] Correspondence

                Ethan A. Natelson, Department of Academic Medicine, Houston Methodist Hospital, Houston, TX, USA.

                Email: eanatelson@ 123456att.net

                © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                Page count
                Figures: 3, Tables: 0, Pages: 6, Words: 4007
                Case Report
                Case Reports
                Custom metadata
                September 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.9 mode:remove_FC converted:16.09.2019


                Comment on this article